La Jolla, California
United States
75
2026-04-30
The entities that hold a legal rights for patent applications filed by inventor SETTE Alessandro:
Alessandro SETTE from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:
MYCOBACTERIUM T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#2 | 2026-02-12ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#3 | 2026-01-01Novel Treatments for Cardiovascular Related Disease
#4 | 2025-11-06Bordetella T Cells Epitopes, Megapools and Uses Thereof
#5 | 2025-10-30CYTOMEGALOVIRUS T CELL EPITOPES AND USES THEREOF
#6 | 2025-07-17Coronavirus T Cell Epitopes, Megapools and Uses Thereof
#7 | 2024-12-12Coronavirus T Cell Epitopes and Uses Thereof
#8 | 2024-09-05Common Cold Coronavirus T Cell Epitopes, Methods and Uses Thereof
#9 | 2024-08-08T CELL TRANSCRIPTOMIC PROFILES IN PARKINSON'S DISEASE, AND METHODS AND USES THEREOF
#10 | 2023-09-21Coronavirus T Cell Epitopes and Uses Thereof
#11 | 2022-08-18HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATORY RESPONSES, AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS
#12 | 2020-09-17TOXOPLASMA GONDII VACCINES AND THEIR USE
#13 | 2020-04-23IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES
#14 | 2020-03-26USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER AND TCR AND/OR HLA IMMUNOPROFILING IN NEURODEGENERATIVE DISEASE
#15 | 2020-01-30Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis
#16 | 2019-09-19TOXOPLASMA GONDII VACCINES AND THEIR USE
#17 | 2019-07-04Immunogenic proteins and fragments thereof from allergenic mites
#18 | 2018-10-11Antigens and T cell epitopes from cockroach and methods of making and using same
#19 | 2018-07-26Peptide combinations and uses thereof for treating grass allergy
#20 | 2018-03-22Epitopes from allergen proteins and methods and uses for immune response modulation
#21 | 2017-06-29USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER
#22 | 2017-02-02Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of
#23 | 2017-02-02HLA-A2 tumor associated antigen peptides and compositions
#24 | 2016-10-06PAN POLLEN IMMUNOGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION
#25 | 2016-09-01Peptide combinations and uses thereof in treating dust mite allergy
#26 | 2016-07-07Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions
#27 | 2016-02-23Inducing cellular immune responses to using peptide and nucleic acid compositions
#28 | 2015-04-23T cell epitopes from Cockroach and methods of making and using same
#29 | 2015-01-22Timothy grass allergens and methods and uses for immune response modulation
#30 | 2015-01-01EPITOPES FROM ALLERGEN PROTEINS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION
#31 | 2014-06-03Heteroclitic analogs and related methods
#32 | 2014-05-29HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS
#33 | 2014-05-22HLA-A2 tumor associated antigen peptides and compositions
#34 | 2014-01-02Antigens and epitopes derived from
#35 | 2013-01-17Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions
#36 | 2012-07-19HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS
#37 | 2012-06-07Virus vaccination and treatment methods with OX40 agonist compositions
#38 | 2012-01-19PLASMODIUM FALCIPARUM ANTIGENS AND METHODS OF USE
#39 | 2011-12-29HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS
#40 | 2011-06-23COMPOSITIONS AND METHODS FOR DENGUE VIRUS (DV) TREATMENT AND VACCINATION
#41 | 2011-04-28Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
#42 | 2010-08-19HLA-A2 tumor associated antigen peptides and compositions
#43 | 2010-03-18Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
#44 | 2010-03-18Optimized multi-epitope constructs and uses thereof
#45 | 2010-02-25Method and System for Optimizing Minigenes and Peptides Encoded Thereby
#46 | 2009-12-24Induction of an immune response against streptococcus pneumoniae polyaccharides
#47 | 2009-12-17Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
#48 | 2009-12-10Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
#49 | 2009-08-27Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
#50 | 2009-07-02Heteroclitic analogs and related methods
#51 | 2009-01-08HLA binding peptides and their uses
#52 | 2008-12-09Method and system for optimizing minigenes and peptides encoded thereby
#53 | 2008-11-13HLA class I A2 tumor associated antigen peptides and vaccine compositions
#54 | 2008-11-06Hla-A2 Tumor Associated Antigen Peptides and Compositions
#55 | 2008-10-23HLA binding motifs and peptides and their uses
#56 | 2007-08-09Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
#57 | 2007-08-07HLA binding peptides and their uses
#58 | 2007-05-03HLA class I A2 tumor associated antigen peptides and vaccine compositions
#59 | 2007-04-10Alteration of immune response using pan DR-binding peptides
#60 | 2007-03-15Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
#61 | 2007-03-08HLA binding motifs and peptides and their uses
#62 | 2007-03-08Methods of identifying optimal variants of peptide epitopes
#63 | 2007-03-08Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
#64 | 2007-03-01Optimized multi-epitope constructs and uses thereof
#65 | 2007-01-25Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
#66 | 2006-07-27antigens and methods of use
#67 | 2006-05-04Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions
#68 | 2006-05-04Peptides for inducing a CTL and/or HTL response to hepatitis C virus
#69 | 2006-04-13Hla binding peptides and their uses
#70 | 2006-04-11Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
#71 | 2006-01-26Heteroclitic analogs and related methods
#72 | 2005-12-08Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
#73 | 2005-09-08Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
#74 | 2005-03-24Inducing cellular immune responses to hepatitis B virus using peptide compositions
#75 | 2005-03-03Induction of immune response against desired determinants
40390 ⎘